Capula Management LTD Horizon Therapeutics Public LTD CO Transaction History

Capula Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$98.98 - $115.74 $17.6 Million - $20.5 Million	177,408 Added 274.46%	242,048 $28 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $9.63 Million - $11.2 Million	-99,946 Reduced 60.73%	64,640 $6.65 Million
Q1 2023 May 10, 2023	BUY	$107.32 - $113.5 $12.4 Million - $13.1 Million	115,192 Added 233.21%	164,586 $18 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $3.08 Million - $5.62 Million	49,394 New	49,394 $5.62 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.